4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-23-027588
Chief Executive Officer gave up 7,172 shares (to pay taxes)
- Chief Executive Officer acquired 24,474 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/rdgdoc.xml…